Home » Drug Discovery Outsourcing Market
Drug Discovery Outsourcing Market
Published date: Feb 2022 •Formats:
Request Sample Schedule a Call

Global Drug Discovery Outsourcing Market Based on Drug Type: (Small Molecules, Large Molecules, Biologics) Based on Workflow: (Target Identification and Screening, Target Validation and Functional Informatics, Others) Based on Therapeutic Area: (Respiratory System, Oncology, Ophthalmology, Hematology, Cardiovascular) by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

  • Published date: Feb 2022
  • Report ID: 83710
  • Number of Pages: 335
  • Format:
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Taxonomy
      • 1.3. Research Scope
      • 1.4. Key Analysis
      • 1.5. Key Findings by Major Segments
      • 1.6. Top strategies by Major Players
    • 2. Global Drug Discovery Outsourcing Overview
      • 2.1. Drug Discovery Outsourcing Dynamics
        • 2.1.1. Drivers
        • 2.1.2. Opportunities
        • 2.1.2. Restraints
        • 2.1.4. Challenges
      • 2.2. Macro-economic Factors
      • 2.3. Regulatory Framework
      • 2.4. Market Investment Feasibility Index
      • 2.5. PEST Analysis
      • 2.6. PORTER’S Five Force Analysis
      • 2.7. Drivers & Restraints Impact Analysis
      • 2.8. Industry Chain Analysis
      • 2.9. Cost Structure Analysis
      • 2.10. Marketing Strategy
      • 2.11. Russia-Ukraine War Impact Analysis
      • 2.12. Opportunity Map Analysis
      • 2.13. Market Competition Scenario Analysis
      • 2.14. Product Life Cycle Analysis
      • 2.15. Opportunity Orbits
      • 2.16. Manufacturer Intensity Map
      • 2.17. Major Companies sales by Value & Volume
    • 3. Global Drug Discovery Outsourcing Analysis, Opportunity and Forecast, 2016-2032
      • 3.1. Global Drug Discovery Outsourcing Analysis, 2016-2021
      • 3.2. Global Drug Discovery Outsourcing Opportunity and Forecast, 2023-2032
      • 3.3. Global Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
        • 3.3.1. Global Drug Discovery Outsourcing Analysis by Drug Type: Introduction
        • 3.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
        • 3.3.3. Small Molecules
        • 3.3.4. Large Molecules
        • 3.3.5. Biologics
      • 3.4. Global Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Workflow, 2016-2032
        • 3.4.1. Global Drug Discovery Outsourcing Analysis by Workflow: Introduction
        • 3.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Workflow, 2016-2032
        • 3.4.3. Target Identification and Screening
        • 3.4.4. Target Validation and Functional Informatics
        • 3.4.5. Lead Identification and Candidate Optimization
        • 3.4.6. Preclinical Development
        • 3.4.7. Others
      • 3.5. Global Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Therapeutic Area, 2016-2032
        • 3.5.1. Global Drug Discovery Outsourcing Analysis by Therapeutic Area: Introduction
        • 3.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Therapeutic Area, 2016-2032
        • 3.5.3. Respiratory System
        • 3.5.4. Oncology
        • 3.5.5. Ophthalmology
        • 3.5.6. Hematology
        • 3.5.7. Cardiovascular
        • 3.5.8. Endocrine
        • 3.5.9. Gastrointestinal
        • 3.5.10. Immunomodulation
        • 3.5.11. Anti-Infective
        • 3.5.12. Central Nervous System
        • 3.5.13. Dermatology
        • 3.5.14. Genitourinary System
    • 4. North America Drug Discovery Outsourcing Analysis, Opportunity and Forecast, 2016-2032
      • 4.1. North America Drug Discovery Outsourcing Analysis, 2016-2021
      • 4.2. North America Drug Discovery Outsourcing Opportunity and Forecast, 2023-2032
      • 4.3. North America Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
        • 4.3.1. North America Drug Discovery Outsourcing Analysis by Drug Type: Introduction
        • 4.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
        • 4.3.3. Small Molecules
        • 4.3.4. Large Molecules
        • 4.3.5. Biologics
      • 4.4. North America Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Workflow, 2016-2032
        • 4.4.1. North America Drug Discovery Outsourcing Analysis by Workflow: Introduction
        • 4.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Workflow, 2016-2032
        • 4.4.3. Target Identification and Screening
        • 4.4.4. Target Validation and Functional Informatics
        • 4.4.5. Lead Identification and Candidate Optimization
        • 4.4.6. Preclinical Development
        • 4.4.7. Others
      • 4.5. North America Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Therapeutic Area, 2016-2032
        • 4.5.1. North America Drug Discovery Outsourcing Analysis by Therapeutic Area: Introduction
        • 4.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Therapeutic Area, 2016-2032
        • 4.5.3. Respiratory System
        • 4.5.4. Oncology
        • 4.5.5. Ophthalmology
        • 4.5.6. Hematology
        • 4.5.7. Cardiovascular
        • 4.5.8. Endocrine
        • 4.5.9. Gastrointestinal
        • 4.5.10. Immunomodulation
        • 4.5.11. Anti-Infective
        • 4.5.12. Central Nervous System
        • 4.5.13. Dermatology
        • 4.5.14. Genitourinary System
      • 4.6. North America Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Country , 2016-2032
        • 4.6.1. North America Drug Discovery Outsourcing Analysis by Country : Introduction
        • 4.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
          • 4.6.2.1. U.S.
          • 4.6.2.2. Canada
          • 4.6.2.3. Mexico
    • 5. Europe Drug Discovery Outsourcing Analysis, Opportunity and Forecast, 2016-2032
      • 5.1. Europe Drug Discovery Outsourcing Analysis, 2016-2021
      • 5.2. Europe Drug Discovery Outsourcing Opportunity and Forecast, 2023-2032
      • 5.3. Europe Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
        • 5.3.1. Europe Drug Discovery Outsourcing Analysis by Drug Type: Introduction
        • 5.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
        • 5.3.3. Small Molecules
        • 5.3.4. Large Molecules
        • 5.3.5. Biologics
      • 5.4. Europe Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Workflow, 2016-2032
        • 5.4.1. Europe Drug Discovery Outsourcing Analysis by Workflow: Introduction
        • 5.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Workflow, 2016-2032
        • 5.4.3. Target Identification and Screening
        • 5.4.4. Target Validation and Functional Informatics
        • 5.4.5. Lead Identification and Candidate Optimization
        • 5.4.6. Preclinical Development
        • 5.4.7. Others
      • 5.5. Europe Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Therapeutic Area, 2016-2032
        • 5.5.1. Europe Drug Discovery Outsourcing Analysis by Therapeutic Area: Introduction
        • 5.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Therapeutic Area, 2016-2032
        • 5.5.3. Respiratory System
        • 5.5.4. Oncology
        • 5.5.5. Ophthalmology
        • 5.5.6. Hematology
        • 5.5.7. Cardiovascular
        • 5.5.8. Endocrine
        • 5.5.9. Gastrointestinal
        • 5.5.10. Immunomodulation
        • 5.5.11. Anti-Infective
        • 5.5.12. Central Nervous System
        • 5.5.13. Dermatology
        • 5.5.14. Genitourinary System
      • 5.6. Europe Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Country , 2016-2032
        • 5.6.1. Europe Drug Discovery Outsourcing Analysis by Country : Introduction
        • 5.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
          • 5.6.2.1. U.K.
          • 5.6.2.2. Germany
          • 5.6.2.3. France
          • 5.6.2.4. Spain
          • 5.6.2.5. Italy
          • 5.6.2.6. Russia
          • 5.6.2.7. Rest of Europe
    • 6. Asia-Pacific Drug Discovery Outsourcing Analysis, Opportunity and Forecast, 2016-2032
      • 6.1. Asia-Pacific Drug Discovery Outsourcing Analysis, 2016-2021
      • 6.2. Asia-Pacific Drug Discovery Outsourcing Opportunity and Forecast, 2023-2032
      • 6.3. Asia-Pacific Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
        • 6.3.1. Asia-Pacific Drug Discovery Outsourcing Analysis by Drug Type: Introduction
        • 6.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
        • 6.3.3. Small Molecules
        • 6.3.4. Large Molecules
        • 6.3.5. Biologics
      • 6.4. Asia-Pacific Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Workflow, 2016-2032
        • 6.4.1. Asia-Pacific Drug Discovery Outsourcing Analysis by Workflow: Introduction
        • 6.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Workflow, 2016-2032
        • 6.4.3. Target Identification and Screening
        • 6.4.4. Target Validation and Functional Informatics
        • 6.4.5. Lead Identification and Candidate Optimization
        • 6.4.6. Preclinical Development
        • 6.4.7. Others
      • 6.5. Asia-Pacific Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Therapeutic Area, 2016-2032
        • 6.5.1. Asia-Pacific Drug Discovery Outsourcing Analysis by Therapeutic Area: Introduction
        • 6.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Therapeutic Area, 2016-2032
        • 6.5.3. Respiratory System
        • 6.5.4. Oncology
        • 6.5.5. Ophthalmology
        • 6.5.6. Hematology
        • 6.5.7. Cardiovascular
        • 6.5.8. Endocrine
        • 6.5.9. Gastrointestinal
        • 6.5.10. Immunomodulation
        • 6.5.11. Anti-Infective
        • 6.5.12. Central Nervous System
        • 6.5.13. Dermatology
        • 6.5.14. Genitourinary System
      • 6.6. Asia-Pacific Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Country , 2016-2032
        • 6.6.1. Asia-Pacific Drug Discovery Outsourcing Analysis by Country : Introduction
        • 6.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
          • 6.6.2.1. China
          • 6.6.2.2. Japan
          • 6.6.2.3. South Korea
          • 6.6.2.4. India
          • 6.6.2.5. Rest of Asia-Pacific
    • 7. South America Drug Discovery Outsourcing Analysis, Opportunity and Forecast, 2016-2032
      • 7.1. South America Drug Discovery Outsourcing Analysis, 2016-2021
      • 7.2. South America Drug Discovery Outsourcing Opportunity and Forecast, 2023-2032
      • 7.3. South America Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
        • 7.3.1. South America Drug Discovery Outsourcing Analysis by Drug Type: Introduction
        • 7.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
        • 7.3.3. Small Molecules
        • 7.3.4. Large Molecules
        • 7.3.5. Biologics
      • 7.4. South America Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Workflow, 2016-2032
        • 7.4.1. South America Drug Discovery Outsourcing Analysis by Workflow: Introduction
        • 7.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Workflow, 2016-2032
        • 7.4.3. Target Identification and Screening
        • 7.4.4. Target Validation and Functional Informatics
        • 7.4.5. Lead Identification and Candidate Optimization
        • 7.4.6. Preclinical Development
        • 7.4.7. Others
      • 7.5. South America Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Therapeutic Area, 2016-2032
        • 7.5.1. South America Drug Discovery Outsourcing Analysis by Therapeutic Area: Introduction
        • 7.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Therapeutic Area, 2016-2032
        • 7.5.3. Respiratory System
        • 7.5.4. Oncology
        • 7.5.5. Ophthalmology
        • 7.5.6. Hematology
        • 7.5.7. Cardiovascular
        • 7.5.8. Endocrine
        • 7.5.9. Gastrointestinal
        • 7.5.10. Immunomodulation
        • 7.5.11. Anti-Infective
        • 7.5.12. Central Nervous System
        • 7.5.13. Dermatology
        • 7.5.14. Genitourinary System
      • 7.6. South America Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Country , 2016-2032
        • 7.6.1. South America Drug Discovery Outsourcing Analysis by Country : Introduction
        • 7.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
          • 7.6.2.1. Brazil
          • 7.6.2.2. Argentina
          • 7.6.2.3. Rest of South America
    • 8. Middle East and Africa Drug Discovery Outsourcing Analysis, Opportunity and Forecast, 2016-2032
      • 8.1. Middle East and Africa Drug Discovery Outsourcing Analysis, 2016-2021
      • 8.2. Middle East and Africa Drug Discovery Outsourcing Opportunity and Forecast, 2023-2032
      • 8.3. Middle East and Africa Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
        • 8.3.1. Middle East and Africa Drug Discovery Outsourcing Analysis by Drug Type: Introduction
        • 8.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
        • 8.3.3. Small Molecules
        • 8.3.4. Large Molecules
        • 8.3.5. Biologics
      • 8.4. Middle East and Africa Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Workflow, 2016-2032
        • 8.4.1. Middle East and Africa Drug Discovery Outsourcing Analysis by Workflow: Introduction
        • 8.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Workflow, 2016-2032
        • 8.4.3. Target Identification and Screening
        • 8.4.4. Target Validation and Functional Informatics
        • 8.4.5. Lead Identification and Candidate Optimization
        • 8.4.6. Preclinical Development
        • 8.4.7. Others
      • 8.5. Middle East and Africa Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Therapeutic Area, 2016-2032
        • 8.5.1. Middle East and Africa Drug Discovery Outsourcing Analysis by Therapeutic Area: Introduction
        • 8.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Therapeutic Area, 2016-2032
        • 8.5.3. Respiratory System
        • 8.5.4. Oncology
        • 8.5.5. Ophthalmology
        • 8.5.6. Hematology
        • 8.5.7. Cardiovascular
        • 8.5.8. Endocrine
        • 8.5.9. Gastrointestinal
        • 8.5.10. Immunomodulation
        • 8.5.11. Anti-Infective
        • 8.5.12. Central Nervous System
        • 8.5.13. Dermatology
        • 8.5.14. Genitourinary System
      • 8.6. Middle East and Africa Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Country , 2016-2032
        • 8.6.1. Middle East and Africa Drug Discovery Outsourcing Analysis by Country : Introduction
        • 8.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
          • 8.6.2.1. GCC
          • 8.6.2.2. Israel
          • 8.6.2.3. South Africa
          • 8.6.2.4. Rest of MEA
    • 9. Global Drug Discovery Outsourcing Analysis, Opportunity and Forecast, By Region , 2016-2032
      • 9.1. Global Drug Discovery Outsourcing Analysis by Region : Introduction
      • 9.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Region , 2016-2032
        • 9.2.1. North America
        • 9.2.2. Europe
        • 9.2.3. Asia-Pacific
        • 9.2.4. South America
        • 9.2.5. Middle East and Africa
    • 10. Global Drug Discovery Outsourcing Competitive Landscape, Market Share Analysis, and Company Profiles
      • 10.1. Market Share Analysis
      • 10.2. Company Profiles
      • 10.3. Charles River Laboratories
        • 10.3.1. Company Overview
        • 10.3.2. Financial Highlights
        • 10.3.3. Product Portfolio
        • 10.3.4. SWOT Analysis
        • 10.3.5. Key Strategies and Developments
      • 10.4. Domainex
        • 10.4.1. Company Overview
        • 10.4.2. Financial Highlights
        • 10.4.3. Product Portfolio
        • 10.4.4. SWOT Analysis
        • 10.4.5. Key Strategies and Developments
      • 10.5. Evotec
        • 10.5.1. Company Overview
        • 10.5.2. Financial Highlights
        • 10.5.3. Product Portfolio
        • 10.5.4. SWOT Analysis
        • 10.5.5. Key Strategies and Developments
      • 10.6. GenScript
        • 10.6.1. Company Overview
        • 10.6.2. Financial Highlights
        • 10.6.3. Product Portfolio
        • 10.6.4. SWOT Analysis
        • 10.6.5. Key Strategies and Developments
      • 10.7. Thermo Fisher Scientific
        • 10.7.1. Company Overview
        • 10.7.2. Financial Highlights
        • 10.7.3. Product Portfolio
        • 10.7.4. SWOT Analysis
        • 10.7.5. Key Strategies and Developments
      • 10.8. Jubilant Biosys Ltd.
        • 10.8.1. Company Overview
        • 10.8.2. Financial Highlights
        • 10.8.3. Product Portfolio
        • 10.8.4. SWOT Analysis
        • 10.8.5. Key Strategies and Developments
      • 10.9. Eurofins Scientific
        • 10.9.1. Company Overview
        • 10.9.2. Financial Highlights
        • 10.9.3. Product Portfolio
        • 10.9.4. SWOT Analysis
        • 10.9.5. Key Strategies and Developments
      • 10.10. Aurigene Pharmaceutical Services Ltd.
        • 10.10.1. Company Overview
        • 10.10.2. Financial Highlights
        • 10.10.3. Product Portfolio
        • 10.10.4. SWOT Analysis
        • 10.10.5. Key Strategies and Developments
      • 10.11. Dalton Pharma Services
        • 10.11.1. Company Overview
        • 10.11.2. Financial Highlights
        • 10.11.3. Product Portfolio
        • 10.11.4. SWOT Analysis
        • 10.11.5. Key Strategies and Developments
      • 10.12. Syngene International Limited
        • 10.12.1. Company Overview
        • 10.12.2. Financial Highlights
        • 10.12.3. Product Portfolio
        • 10.12.4. SWOT Analysis
        • 10.12.5. Key Strategies and Developments
      • 10.13. Others
        • 10.13.1. Company Overview
        • 10.13.2. Financial Highlights
        • 10.13.3. Product Portfolio
        • 10.13.4. SWOT Analysis
        • 10.13.5. Key Strategies and Developments
    • 11. Assumptions and Acronyms
    • 12. Research Methodology
    • 13. Contact

     

    • List of Figures
      • Figure 1: Global Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Drug Type in 2022
      • Figure 2: Global Drug Discovery Outsourcing Market Attractiveness Analysis by Drug Type, 2016-2032
      • Figure 3: Global Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Workflowin 2022
      • Figure 4: Global Drug Discovery Outsourcing Market Attractiveness Analysis by Workflow, 2016-2032
      • Figure 5: Global Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Therapeutic Areain 2022
      • Figure 6: Global Drug Discovery Outsourcing Market Attractiveness Analysis by Therapeutic Area, 2016-2032
      • Figure 7: Global Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Region in 2022
      • Figure 8: Global Drug Discovery Outsourcing Market Attractiveness Analysis by Region, 2016-2032
      • Figure 9: Global Drug Discovery Outsourcing Market Revenue (US$ Mn) (2016-2032)
      • Figure 10: Global Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Region (2016-2032)
      • Figure 11: Global Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
      • Figure 12: Global Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Workflow (2016-2032)
      • Figure 13: Global Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Therapeutic Area (2016-2032)
      • Figure 14: Global Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
      • Figure 15: Global Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
      • Figure 16: Global Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Workflow (2016-2032)
      • Figure 17: Global Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Therapeutic Area (2016-2032)
      • Figure 18: Global Drug Discovery Outsourcing Market Share Comparison by Region (2016-2032)
      • Figure 19: Global Drug Discovery Outsourcing Market Share Comparison by Drug Type (2016-2032)
      • Figure 20: Global Drug Discovery Outsourcing Market Share Comparison by Workflow (2016-2032)
      • Figure 21: Global Drug Discovery Outsourcing Market Share Comparison by Therapeutic Area (2016-2032)
      • Figure 22: North America Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Drug Typein 2022
      • Figure 23: North America Drug Discovery Outsourcing Market Attractiveness Analysis by Drug Type, 2016-2032
      • Figure 24: North America Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Workflowin 2022
      • Figure 25: North America Drug Discovery Outsourcing Market Attractiveness Analysis by Workflow, 2016-2032
      • Figure 26: North America Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Therapeutic Areain 2022
      • Figure 27: North America Drug Discovery Outsourcing Market Attractiveness Analysis by Therapeutic Area, 2016-2032
      • Figure 28: North America Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Country in 2022
      • Figure 29: North America Drug Discovery Outsourcing Market Attractiveness Analysis by Country, 2016-2032
      • Figure 30: North America Drug Discovery Outsourcing Market Revenue (US$ Mn) (2016-2032)
      • Figure 31: North America Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Figure 32: North America Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
      • Figure 33: North America Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Workflow (2016-2032)
      • Figure 34: North America Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Therapeutic Area (2016-2032)
      • Figure 35: North America Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Figure 36: North America Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
      • Figure 37: North America Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Workflow (2016-2032)
      • Figure 38: North America Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Therapeutic Area (2016-2032)
      • Figure 39: North America Drug Discovery Outsourcing Market Share Comparison by Country (2016-2032)
      • Figure 40: North America Drug Discovery Outsourcing Market Share Comparison by Drug Type (2016-2032)
      • Figure 41: North America Drug Discovery Outsourcing Market Share Comparison by Workflow (2016-2032)
      • Figure 42: North America Drug Discovery Outsourcing Market Share Comparison by Therapeutic Area (2016-2032)
      • Figure 43: Europe Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Drug Typein 2022
      • Figure 44: Europe Drug Discovery Outsourcing Market Attractiveness Analysis by Drug Type, 2016-2032
      • Figure 45: Europe Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Workflowin 2022
      • Figure 46: Europe Drug Discovery Outsourcing Market Attractiveness Analysis by Workflow, 2016-2032
      • Figure 47: Europe Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Therapeutic Areain 2022
      • Figure 48: Europe Drug Discovery Outsourcing Market Attractiveness Analysis by Therapeutic Area, 2016-2032
      • Figure 49: Europe Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Country in 2022
      • Figure 50: Europe Drug Discovery Outsourcing Market Attractiveness Analysis by Country, 2016-2032
      • Figure 51: Europe Drug Discovery Outsourcing Market Revenue (US$ Mn) (2016-2032)
      • Figure 52: Europe Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Figure 53: Europe Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
      • Figure 54: Europe Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Workflow (2016-2032)
      • Figure 55: Europe Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Therapeutic Area (2016-2032)
      • Figure 56: Europe Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Figure 57: Europe Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
      • Figure 58: Europe Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Workflow (2016-2032)
      • Figure 59: Europe Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Therapeutic Area (2016-2032)
      • Figure 60: Europe Drug Discovery Outsourcing Market Share Comparison by Country (2016-2032)
      • Figure 61: Europe Drug Discovery Outsourcing Market Share Comparison by Drug Type (2016-2032)
      • Figure 62: Europe Drug Discovery Outsourcing Market Share Comparison by Workflow (2016-2032)
      • Figure 63: Europe Drug Discovery Outsourcing Market Share Comparison by Therapeutic Area (2016-2032)
      • Figure 64: Asia-Pacific Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Drug Typein 2022
      • Figure 65: Asia-Pacific Drug Discovery Outsourcing Market Attractiveness Analysis by Drug Type, 2016-2032
      • Figure 66: Asia-Pacific Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Workflowin 2022
      • Figure 67: Asia-Pacific Drug Discovery Outsourcing Market Attractiveness Analysis by Workflow, 2016-2032
      • Figure 68: Asia-Pacific Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Therapeutic Areain 2022
      • Figure 69: Asia-Pacific Drug Discovery Outsourcing Market Attractiveness Analysis by Therapeutic Area, 2016-2032
      • Figure 70: Asia-Pacific Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Country in 2022
      • Figure 71: Asia-Pacific Drug Discovery Outsourcing Market Attractiveness Analysis by Country, 2016-2032
      • Figure 72: Asia-Pacific Drug Discovery Outsourcing Market Revenue (US$ Mn) (2016-2032)
      • Figure 73: Asia-Pacific Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Figure 74: Asia-Pacific Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
      • Figure 75: Asia-Pacific Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Workflow (2016-2032)
      • Figure 76: Asia-Pacific Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Therapeutic Area (2016-2032)
      • Figure 77: Asia-Pacific Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Figure 78: Asia-Pacific Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
      • Figure 79: Asia-Pacific Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Workflow (2016-2032)
      • Figure 80: Asia-Pacific Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Therapeutic Area (2016-2032)
      • Figure 81: Asia-Pacific Drug Discovery Outsourcing Market Share Comparison by Country (2016-2032)
      • Figure 82: Asia-Pacific Drug Discovery Outsourcing Market Share Comparison by Drug Type (2016-2032)
      • Figure 83: Asia-Pacific Drug Discovery Outsourcing Market Share Comparison by Workflow (2016-2032)
      • Figure 84: Asia-Pacific Drug Discovery Outsourcing Market Share Comparison by Therapeutic Area (2016-2032)
      • Figure 85: South America Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Drug Typein 2022
      • Figure 86: South America Drug Discovery Outsourcing Market Attractiveness Analysis by Drug Type, 2016-2032
      • Figure 87: South America Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Workflowin 2022
      • Figure 88: South America Drug Discovery Outsourcing Market Attractiveness Analysis by Workflow, 2016-2032
      • Figure 89: South America Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Therapeutic Areain 2022
      • Figure 90: South America Drug Discovery Outsourcing Market Attractiveness Analysis by Therapeutic Area, 2016-2032
      • Figure 91: South America Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Country in 2022
      • Figure 92: South America Drug Discovery Outsourcing Market Attractiveness Analysis by Country, 2016-2032
      • Figure 93: South America Drug Discovery Outsourcing Market Revenue (US$ Mn) (2016-2032)
      • Figure 94: South America Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Figure 95: South America Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
      • Figure 96: South America Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Workflow (2016-2032)
      • Figure 97: South America Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Therapeutic Area (2016-2032)
      • Figure 98: South America Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Figure 99: South America Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
      • Figure 100: South America Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Workflow (2016-2032)
      • Figure 101: South America Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Therapeutic Area (2016-2032)
      • Figure 102: South America Drug Discovery Outsourcing Market Share Comparison by Country (2016-2032)
      • Figure 103: South America Drug Discovery Outsourcing Market Share Comparison by Drug Type (2016-2032)
      • Figure 104: South America Drug Discovery Outsourcing Market Share Comparison by Workflow (2016-2032)
      • Figure 105: South America Drug Discovery Outsourcing Market Share Comparison by Therapeutic Area (2016-2032)
      • Figure 106: Middle East and Africa Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Drug Typein 2022
      • Figure 107: Middle East and Africa Drug Discovery Outsourcing Market Attractiveness Analysis by Drug Type, 2016-2032
      • Figure 108: Middle East and Africa Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Workflowin 2022
      • Figure 109: Middle East and Africa Drug Discovery Outsourcing Market Attractiveness Analysis by Workflow, 2016-2032
      • Figure 110: Middle East and Africa Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Therapeutic Areain 2022
      • Figure 111: Middle East and Africa Drug Discovery Outsourcing Market Attractiveness Analysis by Therapeutic Area, 2016-2032
      • Figure 112: Middle East and Africa Drug Discovery Outsourcing Revenue (US$ Mn) Market Share by Country in 2022
      • Figure 113: Middle East and Africa Drug Discovery Outsourcing Market Attractiveness Analysis by Country, 2016-2032
      • Figure 114: Middle East and Africa Drug Discovery Outsourcing Market Revenue (US$ Mn) (2016-2032)
      • Figure 115: Middle East and Africa Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Figure 116: Middle East and Africa Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
      • Figure 117: Middle East and Africa Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Workflow (2016-2032)
      • Figure 118: Middle East and Africa Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Therapeutic Area (2016-2032)
      • Figure 119: Middle East and Africa Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Figure 120: Middle East and Africa Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
      • Figure 121: Middle East and Africa Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Workflow (2016-2032)
      • Figure 122: Middle East and Africa Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Therapeutic Area (2016-2032)
      • Figure 123: Middle East and Africa Drug Discovery Outsourcing Market Share Comparison by Country (2016-2032)
      • Figure 124: Middle East and Africa Drug Discovery Outsourcing Market Share Comparison by Drug Type (2016-2032)
      • Figure 125: Middle East and Africa Drug Discovery Outsourcing Market Share Comparison by Workflow (2016-2032)
      • Figure 126: Middle East and Africa Drug Discovery Outsourcing Market Share Comparison by Therapeutic Area (2016-2032)

       

    • List of Tables
      • Table 1: Global Drug Discovery Outsourcing Market Comparison by Drug Type (2016-2032)
      • Table 2: Global Drug Discovery Outsourcing Market Comparison by Workflow (2016-2032)
      • Table 3: Global Drug Discovery Outsourcing Market Comparison by Therapeutic Area (2016-2032)
      • Table 4: Global Drug Discovery Outsourcing Revenue (US$ Mn) Comparison by Region (2016-2032)
      • Table 5: Global Drug Discovery Outsourcing Market Revenue (US$ Mn) (2016-2032)
      • Table 6: Global Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Region (2016-2032)
      • Table 7: Global Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
      • Table 8: Global Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Workflow (2016-2032)
      • Table 9: Global Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Therapeutic Area (2016-2032)
      • Table 10: Global Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
      • Table 11: Global Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
      • Table 12: Global Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Workflow (2016-2032)
      • Table 13: Global Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Therapeutic Area (2016-2032)
      • Table 14: Global Drug Discovery Outsourcing Market Share Comparison by Region (2016-2032)
      • Table 15: Global Drug Discovery Outsourcing Market Share Comparison by Drug Type (2016-2032)
      • Table 16: Global Drug Discovery Outsourcing Market Share Comparison by Workflow (2016-2032)
      • Table 17: Global Drug Discovery Outsourcing Market Share Comparison by Therapeutic Area (2016-2032)
      • Table 18: North America Drug Discovery Outsourcing Market Comparison by Workflow (2016-2032)
      • Table 19: North America Drug Discovery Outsourcing Market Comparison by Therapeutic Area (2016-2032)
      • Table 20: North America Drug Discovery Outsourcing Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 21: North America Drug Discovery Outsourcing Market Revenue (US$ Mn) (2016-2032)
      • Table 22: North America Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 23: North America Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
      • Table 24: North America Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Workflow (2016-2032)
      • Table 25: North America Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Therapeutic Area (2016-2032)
      • Table 26: North America Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Table 27: North America Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
      • Table 28: North America Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Workflow (2016-2032)
      • Table 29: North America Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Therapeutic Area (2016-2032)
      • Table 30: North America Drug Discovery Outsourcing Market Share Comparison by Country (2016-2032)
      • Table 31: North America Drug Discovery Outsourcing Market Share Comparison by Drug Type (2016-2032)
      • Table 32: North America Drug Discovery Outsourcing Market Share Comparison by Workflow (2016-2032)
      • Table 33: North America Drug Discovery Outsourcing Market Share Comparison by Therapeutic Area (2016-2032)
      • Table 34: Europe Drug Discovery Outsourcing Market Comparison by Drug Type (2016-2032)
      • Table 35: Europe Drug Discovery Outsourcing Market Comparison by Workflow (2016-2032)
      • Table 36: Europe Drug Discovery Outsourcing Market Comparison by Therapeutic Area (2016-2032)
      • Table 37: Europe Drug Discovery Outsourcing Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 38: Europe Drug Discovery Outsourcing Market Revenue (US$ Mn) (2016-2032)
      • Table 39: Europe Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 40: Europe Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
      • Table 41: Europe Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Workflow (2016-2032)
      • Table 42: Europe Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Therapeutic Area (2016-2032)
      • Table 43: Europe Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Table 44: Europe Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
      • Table 45: Europe Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Workflow (2016-2032)
      • Table 46: Europe Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Therapeutic Area (2016-2032)
      • Table 47: Europe Drug Discovery Outsourcing Market Share Comparison by Country (2016-2032)
      • Table 48: Europe Drug Discovery Outsourcing Market Share Comparison by Drug Type (2016-2032)
      • Table 49: Europe Drug Discovery Outsourcing Market Share Comparison by Workflow (2016-2032)
      • Table 50: Europe Drug Discovery Outsourcing Market Share Comparison by Therapeutic Area (2016-2032)
      • Table 51: Asia-Pacific Drug Discovery Outsourcing Market Comparison by Drug Type (2016-2032)
      • Table 52: Asia-Pacific Drug Discovery Outsourcing Market Comparison by Workflow (2016-2032)
      • Table 53: Asia-Pacific Drug Discovery Outsourcing Market Comparison by Therapeutic Area (2016-2032)
      • Table 54: Asia-Pacific Drug Discovery Outsourcing Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 55: Asia-Pacific Drug Discovery Outsourcing Market Revenue (US$ Mn) (2016-2032)
      • Table 56: Asia-Pacific Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 57: Asia-Pacific Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
      • Table 58: Asia-Pacific Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Workflow (2016-2032)
      • Table 59: Asia-Pacific Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Therapeutic Area (2016-2032)
      • Table 60: Asia-Pacific Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Table 61: Asia-Pacific Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
      • Table 62: Asia-Pacific Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Workflow (2016-2032)
      • Table 63: Asia-Pacific Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Therapeutic Area (2016-2032)
      • Table 64: Asia-Pacific Drug Discovery Outsourcing Market Share Comparison by Country (2016-2032)
      • Table 65: Asia-Pacific Drug Discovery Outsourcing Market Share Comparison by Drug Type (2016-2032)
      • Table 66: Asia-Pacific Drug Discovery Outsourcing Market Share Comparison by Workflow (2016-2032)
      • Table 67: Asia-Pacific Drug Discovery Outsourcing Market Share Comparison by Therapeutic Area (2016-2032)
      • Table 68: South America Drug Discovery Outsourcing Market Comparison by Drug Type (2016-2032)
      • Table 69: South America Drug Discovery Outsourcing Market Comparison by Workflow (2016-2032)
      • Table 70: South America Drug Discovery Outsourcing Market Comparison by Therapeutic Area (2016-2032)
      • Table 71: South America Drug Discovery Outsourcing Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 72: South America Drug Discovery Outsourcing Market Revenue (US$ Mn) (2016-2032)
      • Table 73: South America Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 74: South America Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
      • Table 75: South America Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Workflow (2016-2032)
      • Table 76: South America Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Therapeutic Area (2016-2032)
      • Table 77: South America Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Table 78: South America Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
      • Table 79: South America Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Workflow (2016-2032)
      • Table 80: South America Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Therapeutic Area (2016-2032)
      • Table 81: South America Drug Discovery Outsourcing Market Share Comparison by Country (2016-2032)
      • Table 82: South America Drug Discovery Outsourcing Market Share Comparison by Drug Type (2016-2032)
      • Table 83: South America Drug Discovery Outsourcing Market Share Comparison by Workflow (2016-2032)
      • Table 84: South America Drug Discovery Outsourcing Market Share Comparison by Therapeutic Area (2016-2032)
      • Table 85: Middle East and Africa Drug Discovery Outsourcing Market Comparison by Drug Type (2016-2032)
      • Table 86: Middle East and Africa Drug Discovery Outsourcing Market Comparison by Workflow (2016-2032)
      • Table 87: Middle East and Africa Drug Discovery Outsourcing Market Comparison by Therapeutic Area (2016-2032)
      • Table 88: Middle East and Africa Drug Discovery Outsourcing Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 89: Middle East and Africa Drug Discovery Outsourcing Market Revenue (US$ Mn) (2016-2032)
      • Table 90: Middle East and Africa Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 91: Middle East and Africa Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
      • Table 92: Middle East and Africa Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Workflow (2016-2032)
      • Table 93: Middle East and Africa Drug Discovery Outsourcing Market Revenue (US$ Mn) Comparison by Therapeutic Area (2016-2032)
      • Table 94: Middle East and Africa Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Table 95: Middle East and Africa Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
      • Table 96: Middle East and Africa Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Workflow (2016-2032)
      • Table 97: Middle East and Africa Drug Discovery Outsourcing Market Y-o-Y Growth Rate Comparison by Therapeutic Area (2016-2032)
      • Table 98: Middle East and Africa Drug Discovery Outsourcing Market Share Comparison by Country (2016-2032)
      • Table 99: Middle East and Africa Drug Discovery Outsourcing Market Share Comparison by Drug Type (2016-2032)
      • Table 100: Middle East and Africa Drug Discovery Outsourcing Market Share Comparison by Workflow (2016-2032)
      • Table 101: Middle East and Africa Drug Discovery Outsourcing Market Share Comparison by Therapeutic Area (2016-2032)
    • Charles River Laboratories
    • Domainex
    • Evotec
    • GenScript
    • Thermo Fisher Scientific Company Profile
    • Jubilant Biosys Ltd.
    • Eurofins Scientific
    • Aurigene Pharmaceutical Services Ltd.
    • Dalton Pharma Services
    • Syngene International Limited
    • Others
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Drug Discovery Outsourcing Market
  • 83710
  • Feb 2022
    • ★★★★★
      ★★★★★
    • (118)
  • US $5,999
    US $2,999
  • US $7,999
    US $3,499
  • US $12,999
    US $4,499
Buy Now
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$5,999
$2,999
USD / per unit
save 50%
 Multi User
$7,999
$3,499
USD / per unit
save 55%
 Corporate User
$12,999
$4,499
USD / per unit
save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 2,999)Buy Now ($ 3,499)Buy Now ($ 4,499)
auto undefined
af Afrikaanssq Albanianam Amharicar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbn Bengalibs Bosnianbg Bulgarianca Catalanceb Cebuanony Chichewazh-CN Chinese (Simplified)zh-TW Chinese (Traditional)co Corsicanhr Croatiancs Czechda Danishnl Dutchen Englisheo Esperantoet Estoniantl Filipinofi Finnishfr Frenchfy Frisiangl Galicianka Georgiande Germanel Greekgu Gujaratiht Haitian Creoleha Hausahaw Hawaiianiw Hebrewhi Hindihmn Hmonghu Hungarianis Icelandicig Igboid Indonesianga Irishit Italianja Japanesejw Javanesekn Kannadakk Kazakhkm Khmerko Koreanku Kurdish (Kurmanji)ky Kyrgyzlo Laola Latinlv Latvianlt Lithuanianlb Luxembourgishmk Macedonianmg Malagasyms Malayml Malayalammt Maltesemi Maorimr Marathimn Mongolianmy Myanmar (Burmese)ne Nepalino Norwegianps Pashtofa Persianpl Polishpt Portuguesepa Punjabiro Romanianru Russiansm Samoangd Scottish Gaelicsr Serbianst Sesothosn Shonasd Sindhisi Sinhalask Slovaksl Slovenianso Somalies Spanishsu Sundanesesw Swahilisv Swedishtg Tajikta Tamilte Teluguth Thaitr Turkishuk Ukrainianur Urduuz Uzbekvi Vietnamesecy Welshxh Xhosayi Yiddishyo Yorubazu Zulu
Find Help
Legal
Explore